Sort   by:  
 Page size 
UnknownPhase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia.
Not available
S-EPMC3383181 | biostudies-literature
TranscriptomicsInactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients
Micro-RNA expression data of CD19 selected B-cells from previously treated and relapsed chronic lymphocytic leukemia patients. We aimed to correlate miR-34a with TP53 mutation status and del17p status. CD19 B-cells from previously treated and relapsed chronic lymphocytic leukemia patients were selec...
ORGANISM(S): Homo sapiens 
2013-03-21 | E-GEOD-45328 | biostudies-arrayexpress
TranscriptomicsExpression data of chronic lymphocytic leukemia patient samples from the REACH study
We assessed genome-wide expression of available pretreatment specimens from CLL patients enrolled in REACH, a study of fludarabine and cyclophosphamide FC or R-FC (addition of rituximab to FC) in relapsed CLL, to understand the disease heterogeneity and explore genes that may be prognostic or predic...
ORGANISM(S): Homo sapiens 
2014-07-30 | E-GEOD-58211 | biostudies-arrayexpress
Sort   by:  
 Page size